| 1 | Hypersplenism | 31.8% |
| 2 | Thymus Neoplasms | 31% |
| 3 | Abdominal Neoplasms | 27.9% |
| 4 | Head and Neck Neoplasms | 27.9% |
| 5 | Soft Tissue Neoplasms | 27.9% |
| 6 | Thoracic Neoplasms | 27.9% |
| 7 | Hematologic Neoplasms | 26.3% |
| 8 | Splenic Infarction | 24.1% |
| 9 | Lymphocele | 22.8% |
| 10 | Thymoma | 22.1% |
| 11 | Digestive System Neoplasms | 21.8% |
| 12 | Endocrine Gland Neoplasms | 21.8% |
| 13 | Eye Neoplasms | 21.8% |
| 14 | Nervous System Neoplasms | 21.8% |
| 15 | Bone neoplasms | 21.1% |
| 16 | Skin Neoplasms | 21.1% |
| 17 | Adenitis | 20.9% |
| 18 | Histiocytosis | 20.9% |
| 19 | Lymphadenitis | 20.9% |
| 20 | Lymphangitis | 20.9% |
| 21 | Lymphedema | 20.9% |
| 22 | Thymus Hyperplasia | 20.9% |
| 23 | Pseudolymphoma | 20.9% |
| 24 | Lymphadenopathy | 20.9% |
| 25 | Parathyroid Neoplasms | 20.7% |
| 26 | Peritoneal Neoplasms | 20.7% |
| 27 | Thyroid Neoplasm | 20.7% |
| 28 | Thyroid carcinoma | 20.7% |
| 29 | Retroperitoneal Neoplasms | 20.5% |
| 30 | Splenic Rupture | 19.4% |
| 31 | Acanthoma | 19.3% |
| 32 | Tracheal Neoplasms | 18.9% |
| 33 | Paraneoplastic Encephalomyelitis | 18.1% |
| 34 | Pancreatic Neoplasm | 17.8% |
| 35 | Mammary Neoplasms, Experimental | 17.7% |
| 36 | Bone Marrow Neoplasms | 17.6% |
| 37 | Histiocytic Disorders, Malignant | 17.2% |
| 38 | Multiple Endocrine Neoplasia | 16.8% |
| 39 | Thyroid Nodule | 16.7% |
| 40 | Lymphangiectasis, Intestinal | 16.2% |
| 41 | Esophageal Neoplasms | 15.8% |
| 42 | Lymphoproliferative Disorders | 15.8% |
| 43 | Lymphatic Abnormalities | 15.8% |
| 44 | Mouth Neoplasms | 15.5% |
| 45 | Central Nervous System Neoplasms | 15.5% |
| 46 | Vascular Neoplasms | 15.5% |
| 47 | Genital Neoplasms, Female | 15.3% |
| 48 | Carcinoma, Lobular | 15.2% |
| 49 | Breast Neoplasms, Male | 15.1% |
| 50 | Triple Negative Breast Neoplasms | 15.1% |
| 51 | Hamartoma | 14.6% |
| 52 | Neoplasms, Hormone-Dependent | 14.6% |
| 53 | Neoplasms, Multiple Primary | 14.6% |
| 54 | Paraneoplastic Syndromes | 14.6% |
| 55 | Precancerous Conditions | 14.6% |
| 56 | Neoplasms, Second Primary | 14.6% |
| 57 | Carcinoma, Pancreatic Ductal | 14.2% |
| 58 | Meningioma | 14.1% |
| 59 | Splenosis | 14.1% |
| 60 | Testicular Neoplasms | 13.9% |
| 61 | Lymphoma | 13.7% |
| 62 | Elephantiasis | 13.6% |
| 63 | Sarcoidosis | 13.6% |
| 64 | Elephantiasis Nostras Verrucosa | 13.6% |
| 65 | Polycythemia Vera | 13.2% |
| 66 | Multiple Endocrine Neoplasia Type 1 | 12.9% |
| 67 | insulinoma | 12.8% |
| 68 | Vipoma | 12.8% |
| 69 | Gastrinoma | 12.7% |
| 70 | Glucagonoma | 12.7% |
| 71 | Malignant histiocytosis | 12.6% |
| 72 | Meningeal Neoplasms | 12.6% |
| 73 | Histiocytic sarcoma | 12.6% |
| 74 | Adrenal Gland Neoplasms | 12.5% |
| 75 | Gastrointestinal Neoplasms | 12.5% |
| 76 | Genital Neoplasms, Male | 12.5% |
| 77 | Liver neoplasms | 12.5% |
| 78 | Uveal Neoplasms | 12.5% |
| 79 | Mucocutaneous Lymph Node Syndrome | 12.3% |
| 80 | Urologic Neoplasms | 12.3% |
| 81 | Acoustic Neuroma | 12.3% |
| 82 | Sebaceous Gland Neoplasms | 12.2% |
| 83 | Spinal Neoplasms | 12.2% |
| 84 | Carcinoma 256, Walker | 11.8% |
| 85 | Palatal Neoplasms | 11.8% |
| 86 | Leukoplakia, Oral | 11.7% |
| 87 | Paraneoplastic Cerebellar Degeneration | 11.7% |
| 88 | Composite Lymphoma | 11.7% |
| 89 | Nose Neoplasms | 11.4% |
| 90 | Meningeal Carcinomatosis | 11.2% |
| 91 | Carcinoma, Ehrlich Tumor | 11.1% |
| 92 | Dermoid Cyst | 11.1% |
| 93 | Hepatocellular Adenoma | 11.1% |
| 94 | Carcinoma, Lewis Lung | 11.1% |
| 95 | Liver Neoplasms, Experimental | 11.1% |
| 96 | Leydig Cell Tumor | 11.1% |
| 97 | Agammaglobulinemia | 11% |
| 98 | Cyst | 10.9% |
| 99 | Neoplastic Processes | 10.9% |
| 100 | Neoplastic Syndromes, Hereditary | 10.9% |
| 101 | Pregnancy Complications, Neoplastic | 10.9% |
| 102 | Neoplasms, Experimental | 10.7% |
| 103 | Retinoblastoma | 10.7% |
| 104 | Neoplasms, Neuroepithelial | 10.7% |
| 105 | Gliomatosis cerebri | 10.7% |
| 106 | Lymphomatoid Granulomatosis | 10.6% |
| 107 | Sezary Syndrome | 10.6% |
| 108 | Optic Nerve Glioma | 10.6% |
| 109 | Medulloblastoma | 10.5% |
| 110 | Lymphangioleiomyomatosis | 10.4% |
| 111 | Ear Neoplasms | 10.3% |
| 112 | Eyelid Neoplasms | 10.3% |
| 113 | Granuloma | 10.3% |
| 114 | Lung Neoplasms | 10.3% |
| 115 | Pleural Neoplasms | 10.3% |
| 116 | Histiocytosis, Langerhans-Cell | 10.2% |
| 117 | Tumor Lysis Syndrome | 10.2% |
| 118 | Neuroectodermal Tumors | 10.2% |
| 119 | Melanoma, Experimental | 10.2% |
| 120 | Lymphohistiocytosis, Hemophagocytic | 10.1% |
| 121 | Erdheim-Chester Disease | 10.1% |
| 122 | Brain Neoplasms | 10.1% |
| 123 | Heavy Chain Disease | 10.1% |
| 124 | Salivary Gland Neoplasms | 10.1% |
| 125 | Spinal Cord Neoplasms | 10.1% |
| 126 | Tongue Neoplasms | 10.1% |
| 127 | Pituitary Adenoma | 10% |
| 128 | Pituitary Neoplasms | 10% |
| 129 | Hodgkin Disease | 10% |
| 130 | Lymphoma, Non-Hodgkin | 10% |
| 131 | Waldenstrom Macroglobulinemia | 10% |
| 132 | Limbic Encephalitis | 10% |
| 133 | melanoma | 9.9% |
| 134 | Uterine Neoplasms | 9.9% |
| 135 | Vaginal Neoplasms | 9.9% |
| 136 | Vulvar Neoplasms | 9.9% |
| 137 | Uterine Cancer | 9.9% |
| 138 | Fallopian Tube Neoplasms | 9.9% |
| 139 | Trophoblastic Neoplasms | 9.6% |
| 140 | Leukemia, Experimental | 9.5% |
| 141 | Prolactinoma | 9.4% |
| 142 | Growth Hormone-Secreting Pituitary Adenoma | 9.4% |
| 143 | Erythroplasia | 9.3% |
| 144 | Follicular cyst | 9.3% |
| 145 | leukemia | 9.3% |
| 146 | Mucocele | 9.3% |
| 147 | Neoplasms, Germ Cell and Embryonal | 9.3% |
| 148 | Neoplasms, Glandular and Epithelial | 9.3% |
| 149 | Pilonidal Cyst | 9.3% |
| 150 | Thyroglossal Cyst | 9.3% |
| 151 | Synovial Cyst | 9.3% |
| 152 | Germ Cell Cancer | 9.3% |
| 153 | Aberrant Crypt Foci | 9.3% |
| 154 | Leukemia, T-Cell | 9.3% |
| 155 | Leukemia, B-Cell | 9.3% |
| 156 | Carcinosarcoma | 9.2% |
| 157 | Hemangiosarcoma | 9.2% |
| 158 | Leukemia L1210 | 9.2% |
| 159 | Leukemia P388 | 9.2% |
| 160 | lymphangiosarcoma | 9.2% |
| 161 | Adenoma, Acidophil | 9.2% |
| 162 | Ganglioneuroma | 9.2% |
| 163 | Glioma | 9.2% |
| 164 | Malignant Glioma | 9.2% |
| 165 | Bronchial Neoplasms | 9.2% |
| 166 | Nephroblastoma | 9.1% |
| 167 | Multiple Pulmonary Nodules | 9% |
| 168 | Infectious Mononucleosis | 8.9% |
| 169 | Supratentorial Neoplasms | 8.9% |
| 170 | Lambert-Eaton Myasthenic Syndrome | 8.9% |
| 171 | Carcinoid Tumor | 8.9% |
| 172 | Endometrial Neoplasms | 8.9% |
| 173 | Neurilemmoma | 8.9% |
| 174 | Hutchinson's Melanotic Freckle | 8.9% |
| 175 | Melanoma, Amelanotic | 8.9% |
| 176 | Sarcoma 180 | 8.8% |
| 177 | Sarcoma, Experimental | 8.8% |
| 178 | Pharyngeal Neoplasms | 8.7% |
| 179 | ovarian neoplasm | 8.6% |
| 180 | Choriocarcinoma | 8.5% |
| 181 | Neoplasms, Radiation-Induced | 8.5% |
| 182 | Astrocytoma | 8.5% |
| 183 | Ependymoma | 8.5% |
| 184 | oligodendroglioma | 8.5% |
| 185 | Ganglioglioma | 8.5% |
| 186 | gliosarcoma | 8.5% |
| 187 | Anaplastic astrocytoma | 8.5% |
| 188 | Anaplastic Oligodendroglioma | 8.5% |
| 189 | Central Nervous System Cysts | 8.5% |
| 190 | Adrenocortical carcinoma | 8.4% |
| 191 | Bile Duct Neoplasms | 8.4% |
| 192 | gallbladder neoplasm | 8.4% |
| 193 | Intestinal Neoplasms | 8.4% |
| 194 | Penile Neoplasms | 8.4% |
| 195 | Prostatic Neoplasms | 8.4% |
| 196 | Stomach Neoplasms | 8.4% |
| 197 | Brain Stem Neoplasms | 8.3% |
| 198 | Basal cell carcinoma | 8.3% |
| 199 | Carcinoma, Papillary | 8.3% |
| 200 | Squamous cell carcinoma | 8.3% |
| 201 | Chondrosarcoma | 8.3% |
| 202 | Craniopharyngioma | 8.3% |
| 203 | Cystadenoma | 8.3% |
| 204 | leiomyosarcoma | 8.3% |
| 205 | liposarcoma | 8.3% |
| 206 | Mesothelioma | 8.3% |
| 207 | synovial sarcoma | 8.3% |
| 208 | Neuroectodermal Tumor, Melanotic | 8.3% |
| 209 | Angiomyolipoma | 8.3% |
| 210 | Clear Cell Sarcoma of Soft Tissue | 8.3% |
| 211 | Alveolar Soft Part Sarcoma | 8.3% |
| 212 | Neuroendocrine Tumors | 8.3% |
| 213 | Sarcoma, Myeloid | 8.3% |
| 214 | Carcinoma, Basal Cell | 8.3% |
| 215 | Malignant Carcinoid Syndrome | 8.3% |
| 216 | Lymphoma, Follicular | 8.2% |
| 217 | T-Cell Lymphoma | 8.2% |
| 218 | Mantle cell lymphoma | 8.2% |
| 219 | granulosa cell tumor | 8.2% |
| 220 | Carcinoma, Ovarian Epithelial | 8.2% |
| 221 | Glioblastoma | 8.1% |
| 222 | Neuroblastoma | 8.1% |
| 223 | Glioblastoma Multiforme | 8.1% |
| 224 | Disseminated Intravascular Coagulation | 8.1% |
| 225 | Protein S Deficiency | 8.1% |
| 226 | Choroid Plexus Papilloma | 8.1% |
| 227 | Leukemia, Radiation-Induced | 8% |
| 228 | Mesoblastic Nephroma | 8% |
| 229 | Ganglioneuroblastoma | 8% |
| 230 | Cystadenocarcinoma | 7.9% |
| 231 | Fibrosarcoma | 7.9% |
| 232 | Osteosarcoma | 7.9% |
| 233 | Mucoepidermoid Carcinoma | 7.9% |
| 234 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 7.9% |
| 235 | Leukemia, Large Granular Lymphocytic | 7.9% |
| 236 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7.9% |
| 237 | Opsoclonus-Myoclonus Syndrome | 7.8% |
| 238 | Adenofibroma | 7.7% |
| 239 | Fibroadenoma | 7.7% |
| 240 | Malignant Fibrous Histiocytoma | 7.7% |
| 241 | Sarcoidosis, Pulmonary | 7.6% |
| 242 | Hypopharyngeal Neoplasms | 7.5% |
| 243 | Pleural Effusion, Malignant | 7.5% |
| 244 | Hypopharyngeal Cancer | 7.5% |
| 245 | Adenomatous Polyposis Coli | 7.5% |
| 246 | Thrombocythemia, Essential | 7.5% |
| 247 | Laryngeal neoplasm | 7.5% |
| 248 | Tuberous Sclerosis | 7.4% |
| 249 | Bowen's Disease | 7.4% |
| 250 | Paraganglioma | 7.4% |
| 251 | Rhabdomyosarcoma | 7.4% |
| 252 | Giant Cell Tumor of Bone | 7.4% |
| 253 | Parotid Neoplasms | 7.4% |
| 254 | Prostatic Neoplasms, Castration-Resistant | 7.4% |
| 255 | Nelson Syndrome | 7.4% |
| 256 | Lymphoma, T-Cell, Cutaneous | 7.4% |
| 257 | Lymphoma, AIDS-Related | 7.4% |
| 258 | Enteropathy-Associated T-Cell Lymphoma | 7.4% |
| 259 | Primary Effusion Lymphoma | 7.4% |
| 260 | Leukemia, Plasma Cell | 7.3% |
| 261 | Renal Cell Carcinoma | 7.3% |
| 262 | Papillary Renal Cell Carcinoma | 7.3% |
| 263 | Dermatofibrosarcoma | 7.2% |
| 264 | Dermatofibrosarcoma Protuberans | 7.2% |
| 265 | Bladder Neoplasm | 7.1% |
| 266 | Kidney Neoplasm | 7.1% |
| 267 | Ureteral Neoplasms | 7.1% |
| 268 | Urethral Neoplasms | 7.1% |
| 269 | Leukoplakia | 7% |
| 270 | Pancreatic Cyst | 7% |
| 271 | Pheochromocytoma | 7% |
| 272 | Alveolar rhabdomyosarcoma | 7% |
| 273 | Anemia | 7% |
| 274 | Blood Coagulation Disorders | 7% |
| 275 | Blood Platelet Disorders | 7% |
| 276 | Bone Marrow Diseases | 7% |
| 277 | Hemorrhagic Disorders | 7% |
| 278 | Leukocyte Disorders | 7% |
| 279 | Methemoglobinemia | 7% |
| 280 | Pancytopenia | 7% |
| 281 | Polycythemia | 7% |
| 282 | Sulfhemoglobinemia | 7% |
| 283 | Tonsillar Neoplasms | 7% |
| 284 | Carcinoma, Endometrioid | 7% |
| 285 | Thrombophilia | 7% |
| 286 | Erythrocytosis | 7% |
| 287 | Myelitis, Transverse | 7% |
| 288 | Cerebellar Neoplasms | 6.9% |
| 289 | Mycosis Fungoides | 6.9% |
| 290 | Lymphomatoid Papulosis | 6.9% |
| 291 | Plasmablastic lymphoma | 6.9% |
| 292 | Barrett Esophagus | 6.9% |
| 293 | Breast Cyst | 6.9% |
| 294 | Actinic keratosis | 6.9% |
| 295 | Mediastinal Cyst | 6.9% |
| 296 | Neoplasm Invasiveness | 6.9% |
| 297 | Neoplasm Metastasis | 6.9% |
| 298 | Neoplasm Recurrence, Local | 6.9% |
| 299 | Parovarian Cyst | 6.9% |
| 300 | Pericardial Cyst | 6.9% |
| 301 | Thymic Cyst | 6.9% |
| 302 | Carcinogenesis | 6.9% |
| 303 | Myxoid cyst | 6.9% |
| 304 | Autoimmune Lymphoproliferative Syndrome | 6.9% |
| 305 | Metastasis | 6.9% |
| 306 | Adenoma | 6.8% |
| 307 | Ameloblastoma | 6.8% |
| 308 | Angiokeratoma | 6.8% |
| 309 | Carcinoma | 6.8% |
| 310 | Chordoma | 6.8% |
| 311 | Hemangioma | 6.8% |
| 312 | hemangiopericytoma | 6.8% |
| 313 | Lymphangioma | 6.8% |
| 314 | Mesenchymoma | 6.8% |
| 315 | Nevus | 6.8% |
| 316 | Teratoma | 6.8% |
| 317 | Hepatoblastoma | 6.8% |
| 318 | Mixed Tumor, Mullerian | 6.8% |
| 319 | Germinoma | 6.8% |
| 320 | Teratocarcinoma | 6.8% |
| 321 | Angiofibroma | 6.8% |
| 322 | Sarcoma | 6.8% |
| 323 | Epithelioma | 6.8% |
| 324 | Carcinoid Heart Disease | 6.8% |
| 325 | Leukemia, Myelomonocytic, Chronic | 6.7% |
| 326 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 6.7% |
| 327 | Basal Cell Nevus Syndrome | 6.5% |
| 328 | Nasopharyngeal carcinoma | 6.4% |
| 329 | Cecal Neoplasms | 6.3% |
| 330 | Duodenal Neoplasms | 6.3% |
| 331 | Hydatidiform Mole | 6.2% |
| 332 | Thrombasthenia | 6.1% |
| 333 | Antithrombin III Deficiency | 6.1% |
| 334 | Protein C Deficiency | 6.1% |
| 335 | Neurofibrosarcoma | 6.1% |
| 336 | Appendiceal Neoplasms | 5.9% |
| 337 | Colonic Neoplasms | 5.9% |
| 338 | Rectal Neoplasms | 5.9% |
| 339 | Thrombocytosis | 5.9% |
| 340 | Leukemia, Myeloid, Chronic-Phase | 5.8% |
| 341 | Eosinophilic Granuloma | 5.7% |
| 342 | Endometrial Stromal Sarcoma | 5.7% |
| 343 | Nasopharyngeal Neoplasms | 5.6% |
| 344 | Adenocarcinoma | 5.6% |
| 345 | Carcinoma in Situ | 5.6% |
| 346 | Carcinoma, Transitional Cell | 5.6% |
| 347 | Phyllodes Tumor | 5.6% |
| 348 | Dysgerminoma | 5.6% |
| 349 | Hemangioendothelioma | 5.6% |
| 350 | Lipoma | 5.6% |
| 351 | Myoma | 5.6% |
| 352 | Myxoma | 5.6% |
| 353 | Neuroma | 5.6% |
| 354 | Papilloma | 5.6% |
| 355 | Pseudomyxoma Peritonei | 5.6% |
| 356 | Seminoma | 5.6% |
| 357 | Papillomatosis | 5.6% |
| 358 | Angiolipoma | 5.6% |
| 359 | Myelolipoma | 5.6% |
| 360 | Neoplasms, Bone Tissue | 5.6% |
| 361 | Neoplasms, Fibrous Tissue | 5.6% |
| 362 | Smooth Muscle Tumor | 5.6% |
| 363 | Adenomatosis, Pulmonary | 5.6% |
| 364 | Adenomatous Polyps | 5.6% |
| 365 | Carcinoma, Large Cell | 5.6% |
| 366 | Carcinoma, Small Cell | 5.6% |
| 367 | Desmoplastic Small Round Cell Tumor | 5.6% |
| 368 | Chondroma | 5.6% |
| 369 | Enchondroma | 5.6% |
| 370 | Afibrinogenemia | 5.6% |
| 371 | Factor VII Deficiency | 5.6% |
| 372 | Factor X Deficiency | 5.6% |
| 373 | Factor XII Deficiency | 5.6% |
| 374 | Hemophilia A | 5.6% |
| 375 | Activated Protein C Resistance | 5.6% |
| 376 | Factor II deficiency | 5.6% |
| 377 | Factor VIII Deficiency | 5.6% |
| 378 | Factor V deficiency | 5.6% |
| 379 | Factor XI Deficiency | 5.6% |
| 380 | Hypoprothrombinemias | 5.6% |
| 381 | Colorectal Neoplasms | 5.5% |
| 382 | Denys-Drash Syndrome | 5.5% |
| 383 | Transfusion Reaction | 5.5% |
| 384 | Hypotensive Transfusion Reaction | 5.5% |
| 385 | Corpus Luteum Cyst | 5.4% |
| 386 | Ovarian Cysts | 5.4% |
| 387 | Vitamin K Deficiency | 5.4% |
| 388 | Hemangioma, Cavernous | 5.3% |
| 389 | Pregnancy Complications, Hematologic | 5.3% |
| 390 | Burkitt Lymphoma | 5.3% |
| 391 | Pancreatic Pseudocyst | 5.1% |
| 392 | Plasmacytoma | 5.1% |
| 393 | Lymphatic Metastasis | 5% |
| 394 | Neoplasms, Unknown Primary | 5% |
| 395 | Leukemic Infiltration | 5% |
| 396 | Neoplasm Micrometastasis | 5% |
| 397 | Adenoid Cystic Carcinoma | 5% |
| 398 | fibroma | 5% |
| 399 | Fibromatosis | 5% |
| 400 | Osteoblastoma | 5% |
| 401 | Osteoma | 5% |
| 402 | Rhabdomyoma | 5% |
| 403 | Chondromatosis | 5% |
| 404 | Adenocarcinoma, Clear Cell | 5% |
| 405 | Cholangiocarcinoma | 5% |
| 406 | Cervical Intraepithelial Neoplasia | 5% |
| 407 | Hemangioblastoma | 5% |
| 408 | Lymphoma, Extranodal NK-T-Cell | 5% |
| 409 | Paranasal Sinus Neoplasms | 5% |
| 410 | Hemoglobinuria, Paroxysmal | 5% |
| 411 | Leukemoid Reaction | 5% |
| 412 | Multiple Myeloma | 5% |
| 413 | Anus Neoplasms | 5% |
| 414 | Sigmoid Neoplasms | 5% |
| 415 | Fibromatosis, Aggressive | 4.7% |
| 416 | Fibromatosis, Abdominal | 4.7% |
| 417 | Klatskin Tumor | 4.7% |
| 418 | Maxillary Sinus Neoplasms | 4.6% |
| 419 | Choledochal Cyst | 4.6% |
| 420 | Anemia, Hemolytic | 4.5% |
| 421 | Anemia, Macrocytic | 4.5% |
| 422 | Eosinophilia | 4.5% |
| 423 | Hypoproteinemia | 4.5% |
| 424 | Leukopenia | 4.5% |
| 425 | Thrombocytopenia | 4.5% |
| 426 | Leukostasis | 4.5% |
| 427 | MYELODYSPLASTIC SYNDROME | 4.5% |
| 428 | Peutz-Jeghers Syndrome | 4.5% |
| 429 | Anemia, Diamond-Blackfan | 4.4% |
| 430 | Purpura, Thrombotic Thrombocytopenic | 4.1% |
| 431 | Polycystic Ovary Syndrome | 4% |
| 432 | Wiskott-Aldrich Syndrome | 4% |
| 433 | Mastocytoma | 3.8% |
| 434 | Mastocytosis, Systemic | 3.7% |
| 435 | Anemia, Sickle Cell | 3.6% |
| 436 | Thalassemia | 3.6% |
| 437 | Anemia, Neonatal | 3.4% |
| 438 | Leukocytosis | 3.4% |
| 439 | Paraproteinemias | 3.4% |
| 440 | Pelger-Huet Anomaly | 3.4% |
| 441 | Pleocytosis | 3.4% |
| 442 | Mastocytosis | 3.4% |
| 443 | Sturge-Weber Syndrome | 3.4% |
| 444 | Primary Myelofibrosis | 3.4% |
| 445 | Agranulocytosis | 3.4% |
| 446 | Anemia, Megaloblastic | 3.4% |
| 447 | Lymphocytosis | 3.4% |
| 448 | Myelofibrosis | 3.4% |
| 449 | Myeloid Metaplasia | 3.4% |
| 450 | Hypoalbuminemia | 3.4% |
| 451 | Hypereosinophilic syndrome | 3.4% |
| 452 | bone marrow fibrosis | 3.4% |
| 453 | Thrombotic Microangiopathies | 3.4% |
| 454 | Cell Transformation, Viral | 3.4% |
| 455 | Gastrointestinal Stromal Tumors | 3.4% |
| 456 | Primary amyloidosis | 3.4% |
| 457 | Cryoglobulinemia | 3.3% |
| 458 | Monoclonal Gammopathy of Undetermined Significance | 3.3% |
| 459 | neurofibroma | 3.3% |
| 460 | Autoimmune thrombocytopenia | 3.2% |
| 461 | Immune thrombocytopenic purpura | 3.2% |
| 462 | Hemolytic-Uremic Syndrome | 3% |
| 463 | Dupuytren Contracture | 2.9% |
| 464 | Sickle Cell Trait | 2.9% |
| 465 | Purpura, Hyperglobulinemic | 2.8% |
| 466 | Urticaria Pigmentosa | 2.8% |
| 467 | Neutropenia | 2.8% |
| 468 | Hypergammaglobulinemia | 2.8% |
| 469 | Fanconi Anemia | 2.8% |
| 470 | Transfusion-Related Acute Lung Injury | 2.7% |
| 471 | Ecchymosis | 2.7% |
| 472 | Petechiae | 2.7% |
| 473 | Purpura | 2.7% |
| 474 | Xeroderma Pigmentosum | 2.7% |
| 475 | Thrombocytopenic purpura | 2.7% |
| 476 | Atypical Hemolytic Uremic Syndrome | 2.6% |
| 477 | Lymphopenia | 2.6% |
| 478 | Job Syndrome | 2.5% |
| 479 | Febrile Neutropenia | 2.5% |
| 480 | Hydrops Fetalis | 2.4% |
| 481 | Zollinger-Ellison syndrome | 2.2% |
| 482 | Acute Chest Syndrome | 2.2% |
| 483 | Pulmonary Eosinophilia | 2.1% |
| 484 | Eosinophilic Pneumonia | 2.1% |
| 485 | Waterhouse-Friderichsen Syndrome | 2.1% |
| 486 | Anemia, Pernicious | 2.1% |
| 487 | Eosinophilia-Myalgia Syndrome | 2% |
| 488 | Chronic granulomatous disease | 2% |
| 489 | Shwartzman Phenomenon | 2% |
| 490 | Niemann-Pick Disease, Type C | 2% |
| 491 | Scurvy | 2% |
| 492 | Radicular Cyst | 2% |
| 493 | Purpura Fulminans | 2% |
| 494 | Kernicterus | 1.7% |
| 495 | POEMS Syndrome | 1.7% |
| 496 | Pseudoxanthoma Elasticum | 1.1% |